Cargando…
How to prevent viremia rebound? Evidence from a PRRSv data-supported model of immune response
BACKGROUND: Understanding what determines the between-host variability in infection dynamics is a key issue to better control the infection spread. In particular, pathogen clearance is desirable over rebounds for the health of the infected individual and its contact group. In this context, the Porci...
Autores principales: | Go, Natacha, Touzeau, Suzanne, Islam, Zeenath, Belloc, Catherine, Doeschl-Wilson, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352383/ https://www.ncbi.nlm.nih.gov/pubmed/30696429 http://dx.doi.org/10.1186/s12918-018-0666-7 |
Ejemplares similares
-
Integrative Model of the Immune Response to a Pulmonary Macrophage Infection: What Determines the Infection Duration?
por: Go, Natacha, et al.
Publicado: (2014) -
Quantitative Analysis of Porcine Reproductive and Respiratory Syndrome (PRRS) Viremia Profiles from Experimental Infection: A Statistical Modelling Approach
por: Islam, Zeenath U., et al.
Publicado: (2013) -
Cells producing residual viremia during antiretroviral treatment appear to contribute to rebound viremia following interruption of treatment
por: Aamer, Hadega A., et al.
Publicado: (2020) -
Oral Supplementation of Houttuynia cordata Extract Reduces Viremia in PRRSV-1 Modified-Live Virus-Vaccinated Pigs in Response to the HP-PRRSV-2 Challenge
por: Ruansit, Wilawan, et al.
Publicado: (2022) -
Transient detectable viremia and the risk of viral rebound in patients from the Swiss HIV Cohort Study
por: Young, Jim, et al.
Publicado: (2015)